Revisiting the cholinergic hypothesis in the development of Alzheimer's disease

Neuroscience and Biobehavioral Reviews

Volumn 35, Issue 6, 2011, Pages 1397-1409

  Craig, Laura A ^a,b   Hong, Nancy S ^a,b   McDonald, Robert J ^a,b  

^a UNIVERSITY OF LETHBRIDGE   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Acetylcholine; Aging; Alzheimer's disease; Co factors; Hippocampus; Memory

Indexed keywords

ACETYLCHOLINE; BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLINE; CHOLINERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE INHIBITOR; DONEPEZIL; ESTRADIOL; ESTROGEN; NEUROTROPHIN; NICOTINE; PHOSPHATIDYLCHOLINE; PLACEBO;

AGING; ALZHEIMER DISEASE; CEREBROVASCULAR ACCIDENT; CHOLINERGIC SYSTEM; CHOLINERGIC TRANSMISSION; CIRCADIAN RHYTHM; DEGENERATIVE DISEASE; DEMENTIA; DEPLETION; DIET THERAPY; DRUG MECHANISM; EARLY INTERVENTION; HUMAN; HUNTINGTON CHOREA; MEMORY; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEIZURE; STRESS; TRAUMATIC BRAIN INJURY;

ACETYLCHOLINE; AGED; ALZHEIMER DISEASE; HIPPOCAMPUS; HUMANS;

EID: 79954582437     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2011.03.001     Document Type: Review

References (171)

1. Adlard P.A., Perreau V.M., Engesser-Cesar C., Cotman C.W. The time-course of induction of brain-derived neurotrophic factor mRNA and protein in the rat hippocampus following voluntary exercise. Neurosci. Lett. 2004, 363:43-48.
2. Akaike A., Tamura Y., Yokota T., Shimohama S., Kimura J. Nicotine-induced protection of cultured cortical neurons against N-methyl-d-aspartate receptor-mediated glutamate cytotoxicity. Brain Res. 1994, 644:181-187.
3. Alaei H., Moloudi R., Sarkaki A.R., Azizi-Malekabadi H., Hanninen O. Daily running promotes spatial learning and memory in rats. Pathophysiology 2007, 14:105-108.
4. Alzheimer A., Stelzmann R.A., Schnitzlein H.N., Murtagh F.R. An English translation of Alzheimer's 1907 paper, " Uber eine eigenartige Erkankung der Hirnrinde" Clin. Anat. 1995, 8:429-431.
5. Antoniadis E.A., Ko C.H., Ralph M.R., McDonald R.J. Circadian rhythms, aging and memory. Behav. Brain Res. 2000, 111:25-37.
6. Auld D.S., Kar S., Quirion R. Beta-amyloid peptides as direct cholinergic neuromodulators: a missing link?. TINS 1998, 21(1):43-49.
7. Auld D.S., Kornecook T.J., Bastianetto S., Quirion R. Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog. Neurobiol. 2002, 68(3):209-245.
8. Back T., Hemmen T., Schuler O.G. Lesion evolution in cerebral ischemia. J. Neurol. 2004, 251:388-397.
9. Ball M.J., Fisman M., Hachinski V., Blume W., Fox A., Kral V.A., Kirshen A.J., Fox H., Merskey H. A new definition of Alzheimer's disease: a hippocampal dementia. Lancet 1985, 1:14-16.
10. Barrientos R.M., Higgins E.A., Biedenkapp J.C., Sprunger D.B., Wright-Hardesty K.J., Watkins L.R., Rudy J.W., Maier S.F. Peripheral infection and aging interact to impair hippocampal memory consolidation. Neurobiol. Aging 2006, 27:723-732.
11. Bartus R.T. On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp. Neurol. 2000, 163:495-529.
12. Bartus R.T., Dean R.L., Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982, 217:408-414.
13. Bartus R.T., Dean R.L., Goas J.A., Lippa A.S. Age-related changes in passive avoidance retention: modulation with dietary choline. Science 1980, 209:301-303.
14. Bartus R.T. Evidence for a direct cholinergic involvement in the scopolamine-induced amnesia in monkeys: effects of concurrent administration of physostigmine and methylphenidate with scopolamine. Pharmacol. Biochem. Behav. 1978, 9:833-836.
15. Baskerville K.A., Kent C., Nicolle M.N., Gallagher M., McKinney M. Aging causes partial loss of basal forebrain but no loss of pontine reticular cholinergic neurons. Neuroreport 2006, 17:1819-1823.
16. Baskerville K.A., Schweitzer J.B., Herron P. Effects of cholinergic depletion on experience-dependent plasticity in the cortex of the rat. Neuroscience 1997, 80:1159-1169.
17. Belluardo N., Blum M., Mudo G., Andbjer B., Fuxe K. Acute intermittent nicotine treatment produces regional increases of basic fibroblast growth factor messenger RNA and protein in the tel- and diencephalon of the rat. Neuroscience 1998, 83:723-740.
18. Berchtold N.C., Kesslak J.P., Cotman C.W. Hippocampal brain-derived neurotrophic factor gene regulation by exercise and the medial septum. J. Neurosci. Res. 2002, 68(5):511-521.
19. Bizzarro A., Marra C., Acciarri A., Valenza A., Tiziano F.D., Brahe C., Masullo C. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2005, 20(4):254-261.
20. Borlongan C.V., Shytle R.D., Ross S.D., Shimizu T., Freeman T.B., Cahill D.W., Sanberg P.R. (-)-Nicotine protects against systemic kainic acid-induced excitotoxic effects. Exp. Neurol. 1995, 136:261-265.
21. Bowen D.M., Benton J.S., Spillane J.A., Smith C.C.T., Allen S.J. Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients. J. Neurol. Sci. 1982, 57:191-202.
22. Breteler M.M., de Groot R.R., van Romunde L.K., Hofman A. Risk of dementia in patients with Parkinson's disease, epilepsy, and severe head trauma: a register-based follow-up study. Am. J. Epidemiol. 1995, 142:1300-1305.
23. Caplan L.R. Silent brain infarcts. Cerebrovasc. Dis. 1994, 4:32-39.
24. Carlesimo G.A., Oscar-Berman M. Memory deficits in Alzheimer's patients: a comprehensive review. Neuropsychol. Rev. 1992, 3:119-169.
25. Choi S.H., Kim S.Y., Na H.R., Kim B.K., Yang D.W., Kwon J.C., Park M.Y. Effect of ApoE genotype on response to donepezil in patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2008, 25(5):445-450.
26. Connelly P.J., Prentice N.P., Fowler K.G. Predicting the outcome of cholinesterase inhibitor treatment in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2005, 76(3):320-324.
27. Conner J.M., Culberson A., Packowski C., Chiba A.A., Tuszynski M.H. Lesions of the basal forebrain system impair task acquisition and abolish cortical plasticity associated with motor skill learning. Neuron 2003, 38:819-829.
28. Cooper-Kuhn C.M., Winkler J., Kuhn H.G. Decreased neurogenesis after cholinergic forebrain lesion in the adult rat. J. Neurosci. Res. 2004, 77:155-165.
29. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261:921-923.
30. Costa G., Abin-Carriquiry J.A., Dajas F. Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra. Brain Res. 2001, 888(2):336-342.
31. Courtney C., Farrell D., Gray R., Hills R., Lynch L., Sellwood E., Edwards S., Hardyman W., Raftery J., Crome P., Lendon C., Shaw H., Bentham P., AD2000 Collaborative Group Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet 2004, 363:2105-2115.
32. Craig L.A., Hong N.S., Kopp J., McDonald R.J. Selective lesion of medial septal cholinergic neurons followed by a mini-stroke impairs spatial learning in rats. Exp. Brain Res. 2009, 193(1):29-42.
33. Craig L.A., Hong N.S., Kopp J., McDonald R.J. Cholinergic depletion of the medial septum followed by phase shifting does not impair memory or rest-activity rhythms measured under standard light/dark conditions in rats. Brain Res. Bull. 2009, 79(1):53-62.
34. Craig L.A., Hong N.S., Kopp J., McDonald R.J. Reduced cholinergic status in hippocampus produces spatial memory deficits when combined with kainic acid induced seizures. Hippocampus 2008, 18(11):1112-1121.
35. Craig L.A., Hong N.S., Kopp J., McDonald R.J. Emergence of spatial impairment in rats following specific cholinergic depletion of the medial septum combined with chronic stress. Eur. J. Neurosci. 2008, 27:2262-2271.
36. Craig L.A., McDonald R.J. Chronic disruption of circadian rhythms impairs hippocampal memory in the rat. Brain Res. Bull. 2008, 76(1-2). 141,151.
37. Cutuli D., Foti F., Mandolesi L., De Bartolo P., Gelfo F., Federico F., Petrosini L. Cognitive performances of cholinergically depleted rats following chronic donepezil administration. J. Alzheimers Dis. 2009, 17:161-176.
38. 2+ dependent mechanism. Neuropharmacology 2000, 39:2799-2807.
39. Davies P., Maloney A.J. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976, 8000:1403.
40. Davis K.L., Mohs R.C., Marin D., Purohit D.P., Perl D.P., Lantz M., Austin G., Haroutunian V. Cholinergic markers in elderly patients with early signs of Alzheimer's disease. J. Am. Med. Assoc. 1999, 281:1401-1406.
41. de la Torre J.C. Alzheimer disease as a vascular disorder: nosological evidence. Stroke 2002, 33(4):1152-1162.
42. DeKosky S.T., Ikonomovic M.D., Styren S.D., Beckett L., Wisniewski S., Bennett D.A., Cochran E.J., Kordower J.H., Mufson E.J. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann. Neurol. 2002, 51:145-155.
43. Doody R.S., Dunn J.K., Clark C.M., Farlow M., Foster N.L., Liao T., Gonzales N., Lai E., Massman P. Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2001, 12(4):295-300.
44. Drachman D.A., Leavitt J. Human memory and the cholinergic system. A relationship to aging?. Arch. Neurol. 1974, 30:113-121.
45. Drachman D.A. Memory and cognitive function in man: does the cholinergic system have a specific role?. Neurology 1977, 27:783-790.
46. Driscoll I., Hong N.S., Craig L.A., Sutherland R.J., McDonald R.J. Enhanced cell death and learning deficits after a mini-stroke in aged hippocampus. Neurobiol. Aging 2008, 29:1847-1858.
47. Driscoll I., Howard S.R., Stone J.C., Monfils M.H., Tomanek B., Brooks W.M., Sutherland R.J. The aging hippocampus: a multi-level analysis in the rat. Neuroscience 2006, 139:1173-1185.
48. Efange S.M.N., Garland E.M., Staley J.K., Khare A.B., Mash D.C. Vesicular acetylcholine transporter density and Alzheimer's disease. Neurobiol. Aging 1997, 18:407-413.
49. Ehrt U., Broich K., Larsen J.P., Ballard C., Aarsland D. Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study. J. Neurol. Neurosurg. Psychiatry 2010, 81:160-165.
50. Faherty C.J., Kerley D., Smeyne R.J. A Golgi-Cox morphological analysis of neuronal changes induced by environmental enrichment. Dev. Brain Res. 2003, 14:55-61.
51. Fahnestock M., Marchese M., Head E., Pop V., Michalski B., Milgram W.N., Cotman C.W. BDNF increases with behavioral enrichment and an antioxidant diet in the aged dog. Neurobiol. Aging 2010, May 4, Epub ahead of print.
52. Ferencz I., Kokaia M., Keep M., Elmer E., Metsis M., Kokaia Z., Lindvall O. Effects of cholinergic denervation on seizure development and neurotrophin messenger RNA regulation in rapid hippocampal kindling. Neuroscience 1997, 80:389-399.
53. Ferrer I., Krupinski J., Goutan E., Martí E., Ambrosio S., Arenas E. Brain-derived neurotrophic factor reduces cortical cell death by ischemia after middle cerebral artery occlusion in the rat. Acta Neuropathol. 2001, 101:229-238.
54. Finch T.E., Tanzi R.E. Genetics of aging. Science 1997, 278:407-411.
55. Fischer W., Chen K.S., Gage F.H., Bjorklund A. Progressive decline in spatial learning and integrity of forebrain cholinergic neurons in rats during aging. Neurobiol. Aging 1991, 13:9-23.
56. Fisher A. Therapeutic strategies in Alzheimer's disease: M1 muscarinic agonists. Jpn. J. Pharm. 2000, 84(2):101-212.
57. Fleischman D.A., Gabrieli J. Long-term memory in Alzheimer's disease. Curr. Opin. Neurobiol. 1999, 9:240-244.
58. Fujii S., Sumikawa K. Acute and chronic nicotine exposure reverse age-related declines in the induction of long-term potentiation in the rat hippocampus. Brain Res. 2001, 894:347-353.
59. Fujiki M., Kobayashi H., Uchida S., Inoue R., Ishii K. Neuroprotective effect of donepezil, a nicotinic acetylcholine-receptor activator, on cerebral infarction in rats. Brain Res. 2005, 1043:236-241.
60. Geula C., Nagykery N., Nicholas A., Wu C.K. Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2008, 67:309-318.
61. Gibbs R.B. Effects of aging, ovariectomy, and long-term hormone replacement on cholinergic neurons in the medial septum and nucleus basalis magnocellularis. J. Neuroendocrinol. 2003, 15:477-485.
62. Gibbs R. Preclinical data relating to estrogen's effects on cognitive performance. The Effects of Estrogen on Brain Function. The Johns Hopkins 2006, 9-45. University Press, Baltimore. N.L. Rasgon (Ed.).
63. Gibbs R.B. Estradiol enhances DMP acquisition via a mechanism not mediated by turning strategy but which requires intact basal forebrain cholinergic projections. Horm. Behav. 2007, 52:352-359.
64. Gibbs R.B., Gibbs R.B., Mauk R., Nelson D., Johnson D.A. Donepezil treatment restores the ability of estradiol to enhance cognitive performance in aged rats: evidence for the cholinergic basis of the critical period hypothesis. Horm. Behav. 2009, 56:73-83.
65. Gilmore M.L., Erickson J.D., Varoqui H., Hersh L.B., Bennett D.A., Cochran E.J., Mufson E.J., Levey A.I. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. J. Comp. Neurol. 1999, 411(4):693-704.
66. Gonzalez C.L.R., Gharbawie O.A., Kolb B. Chronic low-dose administration of nicotine facilitates recovery and synaptic change after focal ischemia in rats. Neuropharmacology 2006, 50:777-787.
67. Gu Z., Yu J., Perez-Polo J.R. Responses in the aged rat brain after total immunolesion. J. Neurosci. Res. 1998, 54:7-16.
68. Harmon K.M., Wellman C.L. Differential effects of cholinergic lesions on dendritic spines in frontal cortex of young adult and aging rats. Brain Res. 2003, 992:60-68.
69. Hatfield C.F., Herbert J., van Someren E.J.W., Hodges J.R., Hastings M.H. Disrupted daily activity/rest sessions in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer's dementia. Brain 2004, 127:1061-1074.
70. Hauser W.A., Morris M.L., Heston L.L., Anderson V.E. Seizures and myoclonus in patients with Alzheimer's disease. Neurology 1986, 36:1226-1230.
71. Herderschee D., van Gijn J. Silent stroke. Heart Dis. Stroke 1993, 2:343-345.
72. Hesdorffer D.C., Hauser W.A., Annegers J.F., Kokmen E., Rocca W.A. Dementia and adult-onset unprovoked seizures. Neurology 1996, 46:727-730.
73. Hyman B.T., Van Hoesen G.W., Damasio A.R., Barnes C.L. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984, 225:1168-1170.
74. Ickes B.R., Pham T.M., Sanders L.A., Albeck D.S., Mohammed A.H., Granholm A.C. Long-term environmental enrichment leads to regional increases in neurotrophin levels in rat brain. Exp. Neurol. 2000, 164:45-52.
75. Iwasaki K., Egashira N., Hatip-Al-Khatib I., Akiyoshi Y., Arai T., Takagaki Y., Watanabe T., Mishima K., Fujiwara M. Cerebral ischemia combined with beta-amyloid impairs spatial memory in the eight-arm radial maze task in rats. Brain Res. 2006, 1097:216-223.
76. Jaspers R.M.A., Block F., Heim C., Sontag K.H. Spatial learning is affected by transient occlusion of common carotid arteries (2VO): comparison of behavioural and histopathological changes after '2VO' and 'four-vessel-occlusion' in rats. Neurosci. Lett. 1990, 117:149-153.
77. Ji D., Lape R., Dani J.A. Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity. Neuron 2001, 31:131-141.
78. Joseph J., Shukitt-Hale B., Denisova N.A., Martin A., Perry G., Smith M.A. Copernicus revisited: amyloid beta in Alzheimer's disease. Neurobiol. Aging 2001, 22:131-146.
79. Jouvenceau A., Billard J.M., Lamour Y., Dutar P. Persistence of CA1 hippocampal LTP after selective cholinergic denervation. Neuroreport 1996, 7:948-952.
80. Jouvenceau A., Billard J.-M., Lamour Y., Dutar P. Potentiation of glutamatergic EPSPs in rat CA1 hippocampal neurons after selective cholinergic denervation by 192 IgG-Saporin. Synapse 1997, 26:292-300.
81. Kenny P.J., File S.E., Rattray M. Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus. Brain Res. Mol. Brain Res. 2000, 85:234-238.
82. Kilgard M.P., Merzenich M.M. Cortical map reorganization enabled by nucleus basalis activity. Science 1998, 279:1714-1718.
83. Kiyota Y., Miyamoto M., Nagaoka A. Relationship between brain damage and memory impairment in rats exposed to transient forebrain ischemia. Brain. Res. 1991, 538:295-302.
84. Kokaia M., Ferencz I., Leanza G., Elmer E., Metsis M., Kokaia Z., Wiley R.G., Lindvall O. Immunolesioning of basal forebrain cholinergic neurons facilitates hippocampal kindling and perturbs neurotrophin messenger RNA regulation. Neuroscience 1996, 70:313-327.
85. Kolb B., Forgie M., Gibb R., Gorny G., Rowntree S. Age, experience and the changing brain. Neurosci. Biobehav. Rev. 1998, 22:143-159.
86. Kolb B., Gibb R. Environmental enrichment and cortical injury: behavioural and anatomical consequences of frontal cortex lesions. Cereb. Cortex 1991, 1:189-198.
87. Kuhl D.E., Minoshima S., Fessler J.A., Frey K.A., Foster N.L., Ficaro E.P., Wiegland D.M., Koeppe R.A. In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Ann. Neurol. 1996, 40:399-410.
88. Lam T.T, Leranth C. Role of the medial septum diagonal band of Broca cholinergic neurons in oestrogen-induced spine synapse formation on hippocampal CA1 pyramidal cells of female rats. Eur. J. Neurosci. 2003, 17:1997-2005.
89. Larson E.B., Wang L., Bowen J.D., McCormick W.C., Teri L., Crane P., Kukull W. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann. Intern. Med. 2006, 144:73-81.
90. Lemstra A.W., Richard E., van Gool W.A. Cholinesterase inhibitors in dementia: yes, no, or maybe?. Age Aging 2007, 36:625-627.
91. Lupien S.J., de Leon M., de Santi S., Convit A., Tarshish C., Nair N.P.V., Thakur M., McEwen B.S., Hauger R.L., Meaney M.J. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat. Neurosci. 1998, 1:69-73.
92. Madrigal J.L.M., Caso J.R., Cristobal J.D., Cardenas A., Leza J.C., Lizoasoain I., Lorenzo P., Moro M.A. Effect of subacute and chronic immobilization stress on the outcome of permanent focal cerebral ischemia in rats. Brain Res. 2003, 979. 137-135.
93. Maggio R., Riva M., Vaglini F., Fornai F., Molteni R., Armogida M., Racagni G., Corsini G.U. Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors. J. Neurochem. 1998, 71:2439-2446.
94. Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 2000, 20:9104-9110.
95. Martin S.J., Grimwood P.D., Morris R.G.M. Synaptic plasticity and memory: An evaluation of the hypothesis. Ann. Rev. Neurosci. 2000, 23:649-711.
96. Martínez-Rodríguez R., Toledano A., Alvarez M.I., Turégano L., Colman O., Rosés P., Gómez de Segura I., De Miguel E. Chronic nicotine administration increases NGF-like immunoreactivity in frontoparietal cerebral cortex. J. Neurosci. Res. 2003, 73:708-716.
97. Matsuyama S., Matsumoto A., Enomoto T., Nishizaki T. Activation of nicotinic acetylcholine receptors induces long-term potentiation in vivo in the intact mouse dentate gyrus. Eur. J. Neurosci. 2000, 12:3741-3747.
98. McDonald R.J., Craig L.A., Hong N.S. Enhanced cell death in hippocampus and emergence of cognitive impairments following a localized mini-stroke in hippocampus if preceded by a previous episode of acute stress. Eur. J. Neurosci. 2008, 27:2197-2209.
99. McDonald R.J. Multiple combinations of co-factors produce variants of age-related cognitive decline: a theory. Can. J. Exp. Psychol. 2002, 56:221-339.
100. McDonald R.J., Craig L.A., Hong N.S. The etiology of Alzheimer's disease is more complicated than we think. Behav. Brain Res. 2010, 214:3-11.
101. McGaughy J., Everitt B.J., Robbins T.W., Sarter M. The role of cortical cholinergic afferent projections in cognition: impact of new selective immunotoxins. Behav. Brain Res. 2000, 115:251-263.
102. McGeer P.L., McGeer E.G., Suzuki J., Dolman C.E., Nagai T. Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain. Neurology 1984, 34:741-746.
103. McGehee D.S. Nicotinic receptors and hippocampal synaptic plasticity... it's all in the timing. TINS 2002, 25:171-172.
104. Mesulam M. Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles. Neuron 1999, 24:521-529.
105. Mesulam M. The cholinergic lesion of Alzheimer's disease: pivotal factor or side show?. Learn. Mem. 2004, 11:43-49.
106. Mohapel P., Leanza G., Kokaia M., Lindvall O. Forebrain acetylcholine regulates adult hippocampal neurogenesis and learning. Neurobiol. Aging 2005, 26:939-946.
107. Mohs R.C., Doody R.S., Morris J.C., Ieni J.R., Rogers S.L., Perdomo C.A., Pratt R.D. A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients. Neurology 2001, 57:481-488. " 312" Study Group.
108. Montaron M.F., Drapeau E., Dupret D., Kitchener P., Aurousseau C., Le Moal M., Piazza P.V., Abrous D.N. Lifelong corticosterone level deteremines age-related decline in neurogenesis and memory. Neurobiol. Aging 2006, 27:645-654.
109. Mora F., Segovia G., del Arco A. Aging, plasticity and environmental enrichment: structural changes and neurotransmitter dynamics in several areas of the brain. Brain Res. Rev. 2007, 55:78-88.
110. Motooka Y., Kondoh T., Nomura T., Tamaki N., Tozaki H., Kanno T., Nishizaki T. Selective cholinergic denervation inhibits expression of long-term potentiation in the adult but not infant rat hippocampus. Brain Res. Dev. Brain Res. 2001, 129:119-123.
111. Mudo G., Belluardo N., Mauro A., Fuxe K. Acute intermittent nicotine treatment induces fibroblast growth factor-2 in the subventricular zone of the adult rat brain and enhances neuronal precursor cell proliferation. Neuroscience 2007, 145:470-483.
112. Mufson E.J., Counts S.E., Fahnestock M., Ginsberg S.D. Cholinotrophic molecular substrates of mild cognitive impairment in the elderly. Curr. Alzheimer Res. 2007, 4:340-350.
113. Nanri M., Yamamoto J., Miyake H., Watanabe H. Protective effect of GTS-21, a novel nicotinic receptor agonist, on delayed neuronal death induced by ischemia in gerbils. Jpn. J. Pharm. 1998, 76(1):23-29.
114. Nedelmann M., Wilhelm-Schwenkmezger T., Alessandri B., Heimann A., Schneider F., Eicke B.M., Dieterich M., Kempski O. Cerebral embolic ischemia in rats: correlation of stroke severity and functional deWcit as important outcome parameter. Brain. Res. 2007, 1130:188-196.
115. Nilsson M., Perfilieva E., Johansson U., Orwar O., Eriksson P.S. Enriched environment increases neurogenesis in the adult rat dentate gyrus and improves spatial memory. J. Neurobiol. 1999, 39:569-578.
116. Nordberg A. Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications. Biol. Psychiatry 2001, 49(3):200-210.
117. Parent M.B., Baxter M.G. Septohippocampal acetylcholine: involved in but not necessary for learning and memory?. Learn. Mem. 2004, 11:9-20.
118. Pericak-Vance M.A., Haines J.L. Genetic susceptibility to Alzheimer's disease. Trends Genet. 1995, 11:504-508.
119. Perry E.K., Tomlinson B.E., Blessed G., Perry R.H., Cross A.J., Crow T.T. Noradrenergic and cholinergic systems in senile dementia of Alzheimer type. Lancet 1981, 2:8238-8249.
120. Perry E.K., Johnson M., Kerwin J.M., Piggott M.A., Court J.A., Shaw P.J., Ince P.G., Brown A., Perry R.H. Convergent cholinergic activities in aging and Alzheimer's disease. Neurobiol. Aging 1992, 13:393-400.
121. Phillips R.G., Ledoux J.E. Differential contributions of amygdala and hippocampus to cued and contextual fear conditioning. Behav. Neurosci. 1992, 106:274-285.
122. Pop V., Head E., Hill M.A., Gillen D., Bechtold N.C., Muggenburg B.A., Milgram N.W., Murphy M.P., Cotman C.W. Synergistic effects of long-term antioxidant diet and behavioral enrichment on beta-amyloid load and non-amyloidogenic processing in aged canines. J. Neurosci. 2010, 30:9831-9839.
123. Pollak C.P., Perlick D. Sleep problems and institutionalization of the elderly. J. Geriat. Psychiatry Neurol. 1991, 4:204-210.
124. Rapp P.R., Morrison J.H., Roberts J.A. Cyclic estrogen replacement improves cognitive function in aged ovariectomized rhesus monkeys. J. Neurosci. 2003, 23(13):5708-5714. Resnick, S.M., Henderson.
125. Reiter R.J. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB 1995, 9:526-533.
126. Resnick S.M., Henderson V.W. Hormone therapy and risk of Alzheimer disease: a critical time. JAMA 2002, 288(17):2170-2172.
127. Robertson R.T., Gallardo K.A., Clayton K.J., Ha D.H., Ku K.-H., Yu B.P., Lauterborn J.C., Wiley R.G., Yu J., Gall C.M., Leslie F.M. Neonatal treatment with 192 IgG SAPorin produces long-term forebrain cholinergic deficits and reduces branching and spine density of neocortical pyramidal neurons. Cereb. Cort. 1998, 8:142-155.
128. Roe C.M., Xiong C., Miller J.P., Morris J.C. Education and Alzheimer disease without dementia: support for the cognitive reserve hypothesis. Neurology 2007, 68:223-228.
129. Romanelli M.F., Morris J.C., Ashkin K., Coben L.A. Advanced Alzheimer's disease is a risk factor for late-onset seizures. Arch. Neurol. 1990, 47:847-850.
130. Sapolsky R.M. Glucocorticoids, stress, and their adverse neurological effects: relevance to aging. Exp. Gerontol. 1999, 34:721-732.
131. Sassin I., Schultz C., Thal D.R., Rub U., Arai K., Braak E., Braak H. Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert. Acta Neuropathol. 2000, 100:259-269.
132. Schäbitz W.R., Berger C., Kollmar R., Seitz M., Tanay E., Kiessling M., Schwab S., Sommer C. Effect of brain-derived neurotrophic factor treatment and forced arm use on functional motor recovery after small cortical ischemia. Stroke 2004, 35:992-997.
133. Schneider J.A., Arvanitakis Z., Bang W., Bennett D.A. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 2007, 69:2197-2204.
134. Sherren N., Pappas B.A. Selective acetylcholine and dopamine lesions in neonatal rats produce distinct patterns of cortical dendritic atrophy in adulthood. Neuroscience 2005, 136:445-456.
135. Sherwin B.B., Henry J.F. Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review. Front. Neuroendocrinol. 2008, 29(1):88-113.
136. Shin E.J., Chae J.S., Jung M.E., Bing G., Ko K.H., Kim W.K., Wie M.B., Cheon M.A., Nah S.Y., Kim H.C. Repeated intracerebroventricular infusion of nicotine prevents kainate-induced neurotoxicity by activating the alpha7 nicotinic acetylcholine receptor. Epilepsy Res. 2007, 73:292-298.
137. Shors T.J., Miesegaes G., Beylin A., Zhao M., Rydel T., Gould E. Neurogenesis in the adult is involved in the formation of trace memories. Nature 2001, 410:372-376.
138. Silveira D.C., Holmes G.L., Schachter S.C., Geula C., Schomer D.L. Increased susceptibility to generalized seizures after immunolesions of the basal forebrain cholinergic neurons in rats. Brain Res. 2000, 878:223-227.
139. Snowden D.A., Greiner L.H., Mortimer J.A., Riley K.P., Greiner P.A., Markesbery W.R. Brain infarction and the clinical expression of Alzheimer's disease: the nun study. JAMA 1997, 277:813-817.
140. Snyder J.S., Hong N.S., McDonald R.J., Wojtowicz J.M. A role for adult neurogenesis in spatial long-term memory. Neuroscience 2005, 130:843-852.
141. Song I.U., Kim J.S., Kim Y.I., Eah K.Y., Lee K.S. Clinical significance of silent cerebral infarctions in patients with Alzheimer's disease. Cogn. Behav. Neurol. 2007, 20:93-98.
142. Spanswick S.C., Epp J.R., Keith J.R., Sutherland R.J. Adrenalectomy-induced granule cell degeneration in the hippocampus causes spatial memory deficits that are not reversed by chronic treatment with corticosterone or Fluoxetine. Hippocampus 2007, 17:137-146.
143. Srinivasan V., Pandi-Perumal S.R., Cardinali D.P., Poeggeler B., Hardeland R. Melatonin in Alzheimer's disease and other neurodegenerative disorders. Behav. Brain Funct. 2006, 2:15.
144. Stern Y. Cognitive reserve and Alzheimer's disease. Alzheimer. Dis. Assoc. Disord. 2006, 20:112-117.
145. Stevens C.F. A million dollar question: Does LTP=memory?. Neuron 1998, 20:1-2.
146. Stewart R., Liolitsa D. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabetic Med. 1999, 16:93-112.
147. Sutherland R.J., Whishaw I.Q., Kolb B. A behavioural analysis of spatial localization following electrolytic, kainate-or colchicine-induced damage to the hippocampal formation in the rat. Behav. Brain Res. 1983, 7:133-153.
148. Suzuki M., Yamaguchi T., Ozawa Y., Iwai A., Yamamoto M. Effect of YM796, a novel muscarinic agonist, on the impairment of passive avoidance response in senescence-accelerated mice. Pharmacol. Biochem. Behav. 1995, 51:623-626.
149. Suzuki M., Yamaguchi T., Ozawa Y., Ohyama M., Yamamoto M. Effects of (-)-S-2,8-dimethyl-3-methylene-1-oxa-8-azaspiro[4,5]decane l-tartrate monohydrate (YM796), a novel muscarinic agonist, on disturbance of passive avoidance learning behaviour in drug-treated and senescence-accelerated mice. J. Pharmacol. Exp. Ther. 1995, 275:728-736.
150. Suzuki S., Brown C.M., Wise P.M. Mechanisms of neuroprotection by estrogen. Endocrine 2006, 29:209-215.
151. Takada Y., Yonezawa A., Kume T., Katsuki H., Kaneko S., Sugimoto H., Akaike A. Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons. J. Pharmacol. Exp. Ther. 2003, 306:772-777.
152. Tariq M., Khan H.A., Elfaki I., Al Deeb S., Al Moutaery K. Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats. Brain Res. Bull. 2005, 67:161-168.
153. Thompson P.J., Duncan J.S. Cognitive decline in severe intractable epilepsy. Epilepsia 2005, 46:1780-1787.
154. Tong X.K., Nicolakakis N., Kocharyan A., Hamel E. Vascular remodeling versus beta-amyloid induced oxidative stress in the cerebrovascular dysfunctions associated with Alzheimer's disease. J. Neurosci. 2005, 25:11165-11174.
155. van Gool W.A., Witting W., Mirmiran M. Age-related changes in circadian sleep-wakefulness rhythms in male rats isolated from time cues. Brain. Res. 1987, 413:384-387.
156. van Praag H., Kempermann G., Gage F.H. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nat. Neurosci. 1999, 2:266-270.
157. Vaynman S., Ying Z., Gomez-Pinilla F. Hippocampal BDNF mediates the efficacy of exercise on synaptic plasticity and cognition. Eur. J. Neurosci. 2004, 20:2580-2590.
158. Verbois S.L., Hopkins D.M., Scheff S.W., Pauly J.R. Chronic intermittent nicotine administration attenuates traumatic brain injury-induced cognitive dysfunction. Neuroscience 2003, 119:1199-1208.
159. Wahl F., Allix M., Plotkine M., Boulu R.G. Neurological and behavioural outcomes of focal ischemia in rats. Stroke 1992, 23:267-272.
160. Wanibuchi F., Nishida T., Yamashita H., Hidaka K., Koshiya K., Tsukamoto S., Usuda S. Characterization of a novel muscarinic receptor agonist, YM796: comparison with cholinesterase inhibitors in in vivo pharmacological studies. Eur. J. Pharmacol. 1994, 265:151-158.
161. Whitehead S.N., Hachinski V.C., Cechetto D.F. Interaction between a rat model of cerebral ischemia and beta-amyloid toxicity: inflammatory responses. Stroke 2005, 36:107-112.
162. Wilson R.S., Arnold S.E., Schneider J.A., Kelly J.F., Tang Y., Bennett D.A. Chronic psychological distress and risk of Alzheimer's disease in old age. Neuroepidemiology 2006, 27:143-154.
163. Winblad B., Engedal K., Soininen H., Verhey F., Waldemar G., Wimo A., Wetterholm A.L., Zhang R., Haglund A., Subbiah P. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology 2001, 57:489-495. Donepezil Nordic Study Group.
164. Woolley C.S. Acute effects of estrogen on neuronal physiology. Annu. Rev. Pharmacol. Toxicol. 2007, 47:657-680.
165. Works S.J., Wilson R.E., Wellman C.L. Age-dependent effect of cholinergic lesion on dendritic morphology in rat frontal cortex. Neurobiol. Aging 2004, 25:963-974.
166. Wu Y.H., Feenstra M.G.P., Zhou J.N., Liu R.Y., Torano J.S., van Kan H.J.M., Fischer D.F., Ravid R., Swaab D.F. Molecular changes underlying reduced pineal melatonin levels in Alzheimer's disease: alterations in preclinical and clinical stages. J. Clin. Endo. Metab. 2003, 88:5898-5906.
167. Yamaguchi T., Suzuki M., Yamamoto M. YM796, a novel muscarinic agonist, improves the impairment of learning behaviour in a rat model of chronic focal cerebral ischemia. Brain Res. 1995, 669:107-114.
168. Yu J., Pizzo D.P., Hutton L.A., Perez-Polo J.R. Role of the cholinergic system in the regulation of neurotrophin synthesis. Brain Res. 1995, 705:247-252.
169. Zamani M.R., Allen Y.S., Owen G.P., Gray J.A. Nicotine modulates the neurotoxic effect of beta-amyloid protein(25-35) in hippocampal cultures. Neuroreport 2001, 8:513-517.
170. Zarow C., Lyness S.A., Mortimer J.A., Chui H.C. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch. Neurol. 2003, 60:337-341.
171. Zhu X.O., Waite P.M.E. Cholinergic depletion reduces plasticity of barrel field cortex. Cereb. Cort. 1998, 8:63-72.